Susannah Sadler

Health Economics and Outcomes Research (United Kingdom) — United Kingdom

Economics, Econometrics and Finance · Social Sciences

12h-index650citations45works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Health Systems, Economic Evaluations, Quality of Life(8), Heart Failure Treatment and Management(7), Inflammatory Bowel Disease(6), Cardiac Health and Mental Health(5), Biosimilars and Bioanalytical Methods(4)

Publications44 total

Cost-effectiveness analysis of bimekizumab for the treatment of active psoriatic arthritis in Sweden
Journal of Medical Economics·2023· 3 citedOpen Access
Correction to: Comparative efficacy of advanced treatments in biologic-naïve or biologic-experienced patients with ulcerative colitis: a systematic review and network meta-analysis
International Journal of Clinical Pharmacy·2023· 1 citedOpen Access
Comparative efficacy of advanced treatments in biologic-naïve or biologic-experienced patients with ulcerative colitis: a systematic review and network meta-analysis
International Journal of Clinical Pharmacy·2022· 12 citedOpen Access
POSA163 Estimating the Budget Impact of the Introduction of Filgotinib for the Treatment of Ulcerative Colitis in Spain
Value in Health·2022
PGI3 A Network Meta-Analysis to Compare Efficacy of Filgotinib with Other Treatments in Biologic-Naïve Patients with Moderately to Severely Active Ulcerative Colitis
Value in Health·2021· 1 cited
PGI2 A Network Meta-Analysis to Compare Efficacy of Filgotinib with Other Treatments in Biologic-Experienced Patients with Moderately to Severely Active Ulcerative Colitis
Value in Health·2021· 1 cited
A facilitated home-based cardiac rehabilitation intervention for people with heart failure and their caregivers: a research programme including the REACH-HF RCT
Programme Grants for Applied Research·2021· 18 citedOpen Access
Links to full text of published studies and list of other published studies
2021
PMS15 Estimating the Budget IMPACT of the Introduction of Filgotinib for the Treatment of Rheumatoid Arthritis in the UK
Value in Health·2020
PMS16 Cost Effectiveness in Rheumatoid Arthritis: A Systematic Literature Review
Value in Health·2020
PMS17 A Budget IMPACT Analysis of Filgotinib for the Treatment of Adult Patients with Moderate to Severe Rheumatoid Arthritis – a Spanish Healthcare Perspective
Value in Health·2020
PMS19 Validation of a Cost-Effectiveness MODEL in Rheumatoid Arthritis
Value in Health·2020
PMS5 Comparative Efficacy of Filgotinib Versus Alternative Treatments for Rheumatoid Arthritis in Patients with an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drugs: A Systematic Review and Network Meta-Analysis
Value in Health·2020· 1 cited
PMS4 Comparative Efficacy of Filgotinib Versus Alternative Treatments for Rheumatoid Arthritis in Patients with an Inadequate Response to Methotrexate: A Systematic Review and Network Meta-Analysis
Value in Health·2020· 1 cited
Comparing socioeconomic gradients in alcohol-related harm between the four UK countries (PHE Applied Epidemiology Scientific Meeting 18-19 March 2015)
ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam)·2020Open Access
The cost effectiveness of REACH-HF and home-based cardiac rehabilitation in the treatment of heart failure with reduced ejection fraction:a decision model-based analysis
White Rose Research Online (University of Leeds, The University of Sheffield, University of York)·2019· 2 citedOpen Access
The cost effectiveness of REACH-HF and home-based cardiac rehabilitation compared with the usual medical care for heart failure with reduced ejection fraction: A decision model-based analysis
European Journal of Preventive Cardiology·2019· 53 citedOpen Access
The effects and costs of home-based rehabilitation for heart failure with reduced ejection fraction: The REACH-HF multicentre randomized controlled trial
European Journal of Preventive Cardiology·2018· 154 citedOpen Access
A randomised controlled trial of a facilitated home-based rehabilitation intervention in patients with heart failure with preserved ejection fraction and their caregivers: REACH-HFpEF pilot study
British Journal of General Practice·2018· 2 cited
A randomised controlled trial of a facilitated home-based rehabilitation intervention in patients with heart failure with preserved ejection fraction and their caregivers: the REACH-HFpEF Pilot Study
BMJ Open·2018· 116 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Andrew Rawdin(9), Marrissa Martyn‐St James(8), Jean Sanderson(8), Edward Goka(8), Matt Stevenson(8), Neil Gittoes(8), Rod S Taylor(7), Kate Jolly(7), Russell Davis(7), Patrick Doherty(7), Fiona C Warren(7), Jennifer Wingham(7), Colin Greaves(7), Melvyn Hillsdon(7), Charles Abraham(7), Sally Singh(7), Victoria Eyre(7), Chim C. Lang(7), Peter Selby(7), James Dennis(7)